Please assess the completion status of the following clinical trial:

Trial Title: Mass Drug Administrations of DHA-PQP to Accelerate Towards Malaria Elimination in Magude District, Southern Mozambique

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Individuals who consent to participate in the study~* Residents in the study area~* Older than 6 months of age (or weighing more than 5Kg)~* Women in the second or third trimester who are not on IPTp~Exclusion Criteria:~* Individuals who do not consent to participate in the study~* Younger than 6 months of age (or weighing more than 5Kg)~* Women in the first trimester of pregnancy~* Severely ill individuals~* Individuals on contra-indicated medication

- Gender: ALL
- Minimum Age: 6 Months
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Participants (Type: OTHER): Any individual from the study area who participates and is medicated with DHAp in the mass drug administration campaign

Based on this trial design, predict the completion outcome and termination type (if applicable).